A qualitative exploration of perceptions toward pharmaceutical price war among community pharmacists in the state of Penang, Malaysia

Journal of Medical Marketing

Volumn 13, Issue 1, 2013, Pages 44-53

  Hassali, Mohamed Azmi ^a   Siang, Tan Ching ^a   Saleem, Fahad ^a   Aljadhey, Hisham ^b  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Competition Act 2012; Price regulation; Price war; Unethical practice

Indexed keywords

EID: 84879380233     PISSN: 17457904     EISSN: 17457912     Source Type: Journal    
DOI: 10.1177/1745790413477648     Document Type: Article

References (37)

1. Management Sciences for Health, Euro Health Group. Managing drug supply: the selection, procurement, distribution, and use of pharmaceuticals, 2nd edn. Sterling, VA: Kumarian Press, 1997.
2. Schoen C, Osborn R, Doty MM, et al. A survey of primary care physicians in eleven countries, 2009: perspectives on care, costs, and experiences. Health Affairs 2009; 28(6): w1171-w1183.
3. Godman B, Shrank W, Andersen M, et al. Policies to enhance prescribing efficiency in Europe: findings and future implications. Front Pharmacol 2010; 1(141): 1-16.
4. Cameron A, Ewen M, Ross-Degnan D, et al. Medicine prices, availability, and affordability in 36 developing and middleincome countries: a secondary analysis. Lancet 2009; 373(9659): 240-249.
5. Wettermark B, Godman B, Jacobsson B, et al. Soft regulations in pharmaceutical policy making: an overview of current approaches and their consequences. Appl Health Econ Health Policy 2009; 7(3): 137-147.
6. Azmi IM and Alavi R. TRIPS, patents, technology transfer, foreign direct investment and the pharmaceutical industry in Malaysia. J World Intellect Prop 2001; 4(6): 947-976.
7. Babar ZUD, Ibrahim MIM, Singh H, et al. Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia. PLos Med 2007; 4(3): e82.
8. Hassali MA, Shafie AA, Babar ZUD, et al. A study comparing the retail drug prices between Northern Malaysia and Australia. J Pharm Health Serv Res 2012; 3(2): 103-107.
9. Chong CP, Hassali MA, Bahari MB, et al. Evaluating community pharmacists' perceptions of future generic substitution policy implementation: a national survey from Malaysia. Health Policy 2010; 94(1): 68-75.
10. Babar ZUD and Ibrahim MIM. Affordability of medicines in Malaysia-consumer perceptions. Essent Drugs Monit 2003; 33: 18-19.
11. Urbany JE and Dickson PR. Competitive price-cutting momentum and pricing reactions. Mark Lett 1991; 2(4): 393-402.
12. Hassali MA, Shafie AA, Al-Haddad M, et al. A qualitative study exploring the impact of the pharmaceutical price war among community pharmacies in the state of Penang, Malaysia. J Clin Diagn Res 2010; 4(5): 3161-3169.
13. Sorensen AT. Equilibrium price dispersion in retail markets for prescription drugs. J Polit Econ 2000; 108(4): 833-850.
14. Koorhan A. Retail competition-The community level. In: Smith M (ed.) Principles of pharmaceutical marketing, 3rd edn. Philadelphia: Lea & Febiger, 1988, pp. 418-447.
15. Peninsula Research and Development Support Unit. Qualitative Research Methods, http://www.chnri.org/resources/ 1.%20Learning%20Resource%20Material/ Qualitative% 20Research/Monographs/Qualitative%20research%20methods. pdf (2010, accessed 5 December 2012).
16. Berg BL. Qualitative research methods for the social sciences, 5th edn. Boston, MA: Allyn & Bacon, 2004.
17. Polkinghorne DE. Language and meaning: Data collection in qualitative research. J Couns Psychol 2005; 52(2): 137-145.
18. Kemper EA, Stringfield S and Teddlie C. Handbook of mixed methods in social and behavioral research, California: Sage Publications, Inc., 2003.
19. Malaysia Competition Commission (MyCC). Competition Act, http://www.mycc.gov.my/files/announcement/06c727d2-d538-43ba-99fe-40df475d0a8d. pdf (2010, accessed 20 December 2012).
20. Babar ZUD, Izham MIM, Singh H, et al. A survey on medicine prices availability, affordability and price components in Malaysia using the WHO/HAI methodology, http://apps. who.int/medicinedocs/documents/s18599en/s18599en.pdf (2005, accessed 5 December 2012).
21. Malaysia Pharmaceutical Society. Pharmacy requires urgent strategic planning (Part 1), http://www.mps.org.my/newsmaster. cfm?&menuid- 36&action-view&retrieveid-3156 (2010, accessed 20 December 2012).
22. Ewen M and Dey D. Medicines: too costly and too scarce www.haiweb.org/medicineprices/2005/Pricingbriefingpaper FINAL.doc (2005, accessed 10 December 2012).
23. Wertheimer A and Grumer S. Overview of international pharmacy pricing. Pharmacoeconomics 1992; 2(6): 449-455.
24. Kanavos P. Overview of pharmaceutical pricing and reimbursement regulation in Europe. Jpn Pharmacol Ther 2003; 31(10): 819-838.
25. Mahmood M and Bukhari N. Pharmaceutical management and marketing. Faisalabad: Tariq Academy, 2002.
26. Kamat VR and Nichter M. Pharmacies, self-medication and pharmaceutical marketing in Bombay, India. Soc Sci Med 1998; 47(6): 779-794.
27. Scherer FM. The pharmaceutical industry - prices and progress. N Engl J Med 2004; 351(9): 927-932.
28. Taylor D, Mrazek M and Mossialos E. Regulating pharmaceutical distribution and retail pharmacy in Europe. In: Mossialos E, Mrazek M and Walley T (eds) Regulating pharmaceuticals in Europe: striving for efficiency, equity and quality. Maidenhead: Open University Press, 2004, pp.196-212.
29. Malaysian Pharmaceutical Society. An "honest-voice" against unethical promotion, http://www.mps.org.my/newsmaster. cfm?&menuid- 37&action-view&retrieveid-3603 (2012, accessed 15 December 2012).
30. Oorjitham S. Competition countdown: level playing field, http://www.nst.com.my/opinion/columnist/competition-countdown- level-playing-field-1.4678 (2011, accessed 15 December 2012).
31. Shakoor O, Taylor R and Behrens R. Assessment of the incidence of substandard drugs in developing countries. Trop Med Int Health 2003; 2(9): 839-845.
32. Kasim NA, Whitehouse M, Ramachandran C, et al. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol Pharm 2004; 1(1): 85-96.
33. World Health Organization. Counterfeit and substandard drugs in Myanmar and Vietnam, http://apps.who.int/medicinedocs/ pdf/s2276e/s2276e.pdf (1999, accessed 12 December 2012).
34. Daniel S. Police recover drugs stolen from hospital. The Star Online, http://thestar.com.my/news/story.asp?file-/2012/1/3/ nation/ 20120103144404&sec-nation (2012, accessed 15 December 2012).
35. Malaysian Pharmaceutical Society. Drugs on the side-Choose our medicines with care, http://www.mps.org.my/newsmaster. cfm?&menuid-36&action- view&retrieveid-98 (2000, accessed 18 December 2012).
36. Low WY, Ng CJ, Tan NC, et al. Management of erectile dysfunction: barriers faced by general practitioners. Asian J Androl 2004; 6(2): 99-104.
37. Pecoul B, Chirac P, Trouiller P, et al. Access to essential drugs in poor countries. J Am Med Assoc 1999; 281(4): 361-367.